GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract HHSN272201600028CABVIRO LLC

Overview

Award facts

Net obligations
$29.18M
$29,175,011of $29.18M potential value
Outlays (paid to date)
$6.36M
$6.36M paid of $29.18M obligated$6,363,671
Period of performance
Sep 19, 2016 to Sep 30, 2022
Ended
Modifications
22
Latest action Sep 23, 2025
Contract type
Definitive contract
PIID HHSN272201600028C

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

IGF::OT::IGF - A BROAD-SPECTRUM ANTIBODY THERAPEUTIC AGAINST FLAVIVIRUS INFECTIONS.

Dates and value

Award date
Signed on Sep 19, 2016
Potential end of performance
Sep 29, 2022
Current value
$29,175,011Base and exercised options
Potential value (if all options are exercised)
$29,175,011

Obligations by fiscal year of action

  • FY2025: -$229,705 (de-obligation)
  • FY2024: -$34,173 (de-obligation)
  • FY2023: $7,138
  • FY2022: $2,478,476
  • FY2020: $3,186,726
  • FY2019: $5,381,917
  • FY2018: $3,878,629
  • FY2017: $9,353,702
Show all 9 years
  • FY2016: $5,152,302

Total across 9 fiscal years: $29,175,011

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 23, 2025. View on USAspending · Recipient on SAM.gov

Recipient

LocationBETHESDA, MD
UEIK3L6KXJ9B6M7
CAGE code75YF3
Business sizeSmall businessSize at award, per the contracting officer
Organization typePartnership
Parent companyABVIRO LLC

Business types and certifications

For-profit organizationLimited liability companyPartnership or LLP

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIAID
Funded from
National institute of allergy and infectious diseases (0885)Program activities075-0885Federal accounts (agency financial reports)

Place of performance

Place of performance
Bethesda, Montgomery County, Maryland 20814-2934
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Basic researchBR
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
13

Solicitation and notices

Solicitation ID
NIAIDDMIDNIHAI2015037(as reported)

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
Yes
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not a bundled requirementD
Consolidated requirement
No
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 19, 2016Base obligation at award: $5,152,302
Latest action
Sep 23, 2025 — Funding onlyModification P00022; obligation change -$229,705; funding only: changes obligations, not scope
Latest substantive action
Jun 23, 2022 — Supplemental agreement (within scope)Modification P00016
Latest funding action
Sep 23, 2025 — Funding onlyModification P00022; obligation change -$229,705; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Supplemental agreement (within scope)7
  • Funding only6
  • Option exercised4
  • Other administrative action4
  • Change order1
23 actions recorded, Sep 19, 2016 to Sep 23, 2025; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$229,705
Latest action: change in base and all options
-$229,705

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N930
Transactions recorded under this award key
23

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N930
Treasury accounts
  • 075-2017/2017-0885-000
  • 075-2018/2018-0885-000
  • 075-2019/2019-0885-000
  • 075-2020/2020-0885-000
  • 075-2022/2022-0885-000
  • 075-2023/2023-0885-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression